New Modaplex Assays
October 1,

2019

New Modaplex Assays

Dresden-Hellerau, 1st October 2019.

Biotype launches three new assays on its molecular diagnostic platform MODAPLEXTM:

The kits (research use only) enable the detection of 13 KRAS, 13 NRAS, and 4 BRAF (KNB) mutations together in a single run. The Modaplex system thus offers a fast, simple, and sensitive approach for a comprehensive KNB mutation analysis.

The three assays further broaden Biotype’s existing portfolio for the Modaplex system in the area of oncology.

Further information about all KNB assays can be found here.

 

 

 

Share This :